E
81.53
1.82 (2.28%)
| Penutupan Terdahulu | 79.71 |
| Buka | 80.14 |
| Jumlah Dagangan | 4,040,065 |
| Purata Dagangan (3B) | 4,867,129 |
| Modal Pasaran | 47,352,623,104 |
| Harga / Pendapatan (P/E TTM) | 45.04 |
| Harga / Pendapatan (P/E Ke hadapan) | 27.25 |
| Harga / Jualan (P/S) | 7.82 |
| Harga / Buku (P/B) | 4.52 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 23 Apr 2026 |
| Margin Keuntungan | 75.71% |
| Margin Operasi (TTM) | 29.01% |
| EPS Cair (TTM) | 2.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.86% |
| Nisbah Semasa (MRQ) | 4.45 |
| Aliran Tunai Operasi (OCF TTM) | 876.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.45 B |
| Pulangan Atas Aset (ROA TTM) | 8.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 16.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Edwards Lifesciences Corporatio | Menaik | Menaik |
AISkor Stockmoo
-0.9
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | -3.5 |
| Osilator Teknikal | -2.0 |
| Purata | -0.90 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.91% |
| % Dimiliki oleh Institusi | 89.29% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 103.00 (BTIG, 26.33%) | Beli |
| Median | 100.00 (22.65%) | |
| Rendah | 89.00 (Truist Securities, 9.16%) | Pegang |
| Purata | 97.40 (19.47%) | |
| Jumlah | 4 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 79.33 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 11 Feb 2026 | 103.00 (26.33%) | Beli | 79.33 |
| Goldman Sachs | 11 Feb 2026 | 95.00 (16.52%) | Beli | 79.33 |
| Piper Sandler | 11 Feb 2026 | 100.00 (22.65%) | Beli | 79.33 |
| Truist Securities | 11 Feb 2026 | 89.00 (9.16%) | Pegang | 79.33 |
| Wells Fargo | 11 Feb 2026 | 100.00 (22.65%) | Beli | 79.33 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Feb 2026 | Pengumuman | Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 |
| 02 Feb 2026 | Pengumuman | Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |